Professor Jonathan Emberson
BA, MSc, PhD
Professor of Medical Statistics and Epidemiology
- MRC Population Health Research Unit Programme Leader
- NDPH Deputy Director of Graduate Studies
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. In particular, he is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Body mass index and COVID-19 mortality: prospective study of 120,000 Mexican adults
EMBERSON J. et al, (2022), International Journal of Epidemiology
Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy
EMBERSON J. et al, (2022), Clinical Trials
Allocated but not treated: the silent 16% - Authors' reply.
Horby P. et al, (2022), Lancet, 399, 1775 - 1776
Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study.
Bragg F. et al, (2022), BMC Med, 20
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
RECOVERY Collaborative Group None. et al, (2022)